Safety and immunogenicity of a conjugate vaccine against Haemophilus influenzae type b in splenectomized and nonsplenectomized patients with Cooley anemia

Journal of Infectious Diseases

Volumn 183, Issue 12, 2001, Pages 1819-1821

  Cimaz, Rolando ^a   Mensi, Carolina ^b   D’Angelo, Emanuela ^a   Fantola, Elisabetta ^a   Milone, Vittoria ^a   Biasio, Luigi R ^c   Carnelli, Vittorio ^a   Zanetti, Alessandro R ^b  

^a Istituti Clinici di Perfezionamento   (United States)

^b UNIVERSITY OF MILAN   (Italy)

^c MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HAEMOPHILUS VACCINE;

ADOLESCENT; ADULT; ARTICLE; CHILD; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG SAFETY; FEMALE; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; IMMUNITY; IMMUNIZATION; IMMUNOGENICITY; INFECTION RISK; INFLUENZA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPHYLAXIS; RISK FACTOR; SPLENECTOMY; THALASSEMIA MAJOR; VACCINATION;

ADOLESCENT; ADULT; ANTIBODIES, BACTERIAL; BETA-THALASSEMIA; CHILD; CHILD, PRESCHOOL; FEMALE; HAEMOPHILUS INFLUENZAE TYPE B; HAEMOPHILUS VACCINES; HUMANS; IMMUNIZATION SCHEDULE; IMMUNIZATION, SECONDARY; MALE; SAFETY; SPLEEN; SPLENECTOMY; TIME FACTORS; VACCINES, CONJUGATE;

EID: 0035876898     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/320727     Document Type: Article

References (15)

1. Abnormalities in the immune system of children with β-thalassemia mayor
2. Increased risk of sepsis after splenectomy
3. Impaired immune response of splenectomized patients to polyvalent pneumococcal vaccine
4. Immune response after splenectomy
5. Opsonic requirements for intravascular clearance after splenectomy
6. Global programme for vaccines and immunization (GPV): The WHO position paper on Haemophilus influenzae type b conjugate vaccines
7. Anticapsular antibody requirements for protection against experimental Haemophilus influenzae type b bacteremia after splenectomy
8. Antibody response to a Haemophilus influenzae type b polysaccharide tetanus toxoid conjugate vaccine in splenectomized children and adolescents
9. Antibody levels against Streptococcus pneumoniae and Haemophilus influenzae type b in a population of splenectomized individuals with varying vaccination status
10. Normal IgG and impaired IgM response to polysaccharide vaccines in asplenic patients
11. Immune responses to administration of a vaccine against Haemophilus influenzae type B in splenectomized and non-splenectomized patients
12. The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b
13. A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease
14. Ten years experience with Haemophilus influenzae type b (Hib) conjugate vaccines in Finland
15. Antibody concentration and clinical protection after Hib conjugate vaccination in the United Kingdom